Search

Displaying results 7661 - 7670 of 10000 in total
  1. Drug

    Pulrodemstat

    go.drugbank.com/drugs/DB21497
    Experimental

    The usage of the INN stem '-demstat' in the name indicates that Pulrodemstat is a Lysine-specific histone demethylase inhibitor. Pulrodemstat has a monoisotopic molecular weight of 451.18 Da.

  2. Drug

    Zavolosotine

    go.drugbank.com/drugs/DB21531
    Experimental

    The usage of the INN stem '-sotine' in the name indicates that Zavolosotine is a non-peptidic somatostatin receptor agonist. Zavolosotine has a monoisotopic molecular weight of 439.14 Da.

  3. Drug

    Branosotine

    go.drugbank.com/drugs/DB21674
    Experimental

    The usage of the INN stem '-sotine' in the name indicates that Branosotine is a non-peptidic somatostatin receptor agonist. Branosotine has a monoisotopic molecular weight of 471.22 Da.

  4. Drug

    Estrane-3,17-dione

    go.drugbank.com/drugs/DB04693
    Experimental

    Estrane-3,17-dione is a potent inhibitor of isomerase.

  5. Drug

    Navarixin

    go.drugbank.com/drugs/DB11711
    Investigational

    Navarixin has been investigated for the treatment of Asthma.

  6. Drug

    SB-218078

    go.drugbank.com/drugs/DB17051
    Experimental

    SB-218078 is a specific inhibitor of CHK1.[A253117]

    Synonyms: 9,10,11,12-tetrahydro-9,12-epoxy-1h-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocine-1,3(2h)-dione, 9,12-epoxy-1h-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocine-1,3(2h)-dione, 9,10,11,12-tetrahydro-
  7. Drug

    MK-886

    go.drugbank.com/drugs/DB16739
    Experimental

    MK-886 is an experimental inhibitor of leukotriene synthesis.

  8. Drug

    Sarcosine

    go.drugbank.com/drugs/DB12519
    Investigational

    Sarcosine has been investigated for the treatment of Schizophrenia.

  9. Drug

    Pyronaridine

    go.drugbank.com/drugs/DB12975
    Investigational

    Pyronaridine has been investigated for the treatment of Malaria.

  10. Drug

    Prostaglandin D2

    go.drugbank.com/drugs/DB02056
    Experimental

    The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages.